Last reviewed · How we verify

NCT07429578: NewWaves

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

Recruiting now NA Last updated 24 February 2026
What this trial tests

NA trial testing Transcranial Alternating Current Stimulation (tACS) in Generalized Anxiety Disorder (GAD) in 30 participants. Currently enrolling.

Timeline
1 June 2025
Primary endpoint
31 January 2026
31 May 2026

Quick facts

Lead sponsorUniversity of Sao Paulo
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 June 2025
Primary completion31 January 2026
Estimated completion31 May 2026
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

University of Sao Paulo

Who can join

Adults 18 to 65, any sex, with Generalized Anxiety Disorder (GAD) or Chronic Insomnia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an open-label pilot clinical trial to evaluate the effects of transcranial alternating current stimulation (tACS) in adults diagnosed with generalized anxiety disorder (GAD) and chronic primary insomnia. The study will involve 30 participants who will receive 20 sessions of tACS over four weeks. The stimulation will be delivered at 15 mA and 77.5 Hz using the Nexalin device. The main goal is to assess improvements in anxiety and sleep quality. Results from this study will provide preliminary evidence for future randomized controlled trials.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcranial Alternating Current Stimulation (tACS)

Trials testing the same drug.

Other recruiting trials for Generalized Anxiety Disorder (GAD)

Currently open trials in the same condition.

Other University of Sao Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07429578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing